ORIC PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $6.1M | $94.1M | $89.2M |
| FY2020 | $9.2M | $299.0M | $78.4M |
| FY2021 | $25.7M | $298.6M | $226.0M |
| FY2022 | $24.8M | $247.2M | $66.8M |
| FY2023 | $27.9M | $252.0M | $23.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $6.1M | $94.1M | $89.2M |
| FY2020 | $9.2M | $299.0M | $78.4M |
| FY2021 | $25.7M | $298.6M | $226.0M |
| FY2022 | $24.8M | $247.2M | $66.8M |
| FY2023 | $27.9M | $252.0M | $23.4M |